Study of plasma exchange for liver failure: Beneficial and harmful effects

Therapeutic Apheresis and Dialysis

Volumn 8, Issue 3, 2004, Pages 180-184

  Abe, Takaya ^a,b   Kobata, Hirotsugu ^b   Hanba, Yoshiyuki ^b   Kitabata, Yukiko ^b   Narukawa, Nobuhiko ^b   Hasegawa, Hirohito ^b   Abe, Tomiya ^c   Fukagawa, Masafumi ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^c Nakaya Hospital   (Japan)

Author keywords

Acetate; Citrate; Human Hepatocyte Growth Factor (HGF); Plasma exchange

Indexed keywords

ACETIC ACID; BICARBONATE; CALCIUM ION; CITRIC ACID; ELECTROLYTE; FRESH FROZEN PLASMA; POTASSIUM ION; SCATTER FACTOR; TOXIN;

ACIDIFICATION; ADULT; AGED; ARTIFICIAL KIDNEY; CLINICAL ARTICLE; CONFERENCE PAPER; DIALYSATE; ELECTROLYTE BLOOD LEVEL; ELECTROLYTE DISTURBANCE; FEMALE; HEMODIALYSIS; HUMAN; LIVER FAILURE; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME;

ACETATES; AGED; CALCIUM; CITRIC ACID; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LIVER FAILURE; MALE; MIDDLE AGED; PLASMA EXCHANGE; POTASSIUM; RENAL DIALYSIS; SODIUM; TREATMENT OUTCOME;

EID: 3142618951     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-0968.2004.00149.x     Document Type: Conference Paper

References (16)

1. Lepore MJ, Mckenna PJ, Martinez DB, Stutman LJ, Bonanno CA, Conklin EF. Fulminant Hepatitis with Coma Successfully Treated by Plasmapheresis and Hyperimmune Australia-Antibody-Rich Plasma. Am J Gastroenterol 1972;58:381-9.
2. Mokrzycki MH, Kaplan AA. Theapeutic Plasma Exchange. Complications and Management. Am J Kidney Dis 1994;23:817-27.
3. Kita Y, Uchita K, Kajimoto Y, Taniguchi M, Kusumi H, Abe T. Study of Plasma-Exchange Combined with Bicarbonate Dialysis Using Various Substitution Fluids. Therapeutic Plasmapheresis 1982;11:155-8.
4. Kaplan AA, Epstein M. Extracorporeal Blood Purification in the Management of Patients With Hepatic Failure. Semin Nephrol 1997;17:576-82.
5. Yorgin PD, Eklund DK, al-Uzri A, Whitesell L. Concurrent centrifugation plasmapheresis and continuous venovenous hemodiafiltration. Pediatr Nephrol 2000;14:18-21.
6. Yoshiba M, Inoue K, Sekiyama K, Koh I. Favorable Effect of New Artificial Liver Support on Survival of Patients with Fulminant Hepatic Failure. Artif Organs 1996;20:1169-72.
7. Sadahiro T, Hirasawa H, Oda S et al. Usefulness of plasma exchange plus continuous hemodiafiltration to reduce adverse effect associated with plasma exchange in patients with acute liver failure. Crit Care Med 2001;29:1386-92.
8. Nakae H, Yonekawa C, Wada H, Asanuma Y, Sato T, Tanaka H. Effectiveness of Combining Plasma Exchange and Continuous Hemodiafiltration (Combined Modality Therapy in a Parallel Circuit) in the Treatment of Patients with Acute Hepatic Failure. Ther Apher 2001;5:471-5.
9. Lundquist F. Production and utilization of free acetate in man. Nature 1962;193:579-80.
10. Jacob AD, Elkins N, Reiss OK, Chan L, Shapiro JI. Effects of acetate on energy metabolism and function in the isolated perfused rat heart. Kidney Int 1997;52:755-60.
11. Amore A, Cirina P, Mitola S et al. Acetate Intolerance Is Mediated by Enhanced Synthesis of Nitric Oxide by Endothelial Cells. J Am Soc Nephrol 1997;8:1431-6.
12. Bingel M, Lonnemann G, Koch KM, Dinarello CA, Shaldon S. Enhancement of in-vitro human interleukin-1 poduction by sodium acetate. Lancet 1987;1:14-6.
13. Zucchelli P, Santoro A, Salvadeo S et al. Acetate-Free Biofiltration (AFBF): an Attractive Alternative to Bicarbonate Dialysis (BD). Blood Purif 1987;5:319.
14. Carozzi S, Nasini MG, Caviglia PM, Schelotto C, Santoni O, Atti M. Acetate Free Biofiltration: Effect on peripheral blood monocyte activation and cytokine release. ASAIO J 1992;38:52-4.
15. Bandiani G, Camaiora E, Farina D, Nicolini MA, Perotta U, Tagliazucchi A. Long-term influence of dialysis treatment on β2-microglobulin, interleukin-2R and tumor necrosis factor. Nephrol Dial Transplant 1991:6 Suppl. 2;61-3.
16. Higuchi T, Kuno T, Takahashi S, Kanmatsuse K. Chronic effects of long-term acetate-free biofiltration on the production of interleukin-1β and interleukin-1 receptor antagonist by peripheral blood mononuclear cells. Am J Nephrol 1997;17:428-34.